One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2021-145626
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2021 |
 Citations: 11 |
Affiliation: Yale University, Yale Cancer Center, Hospital Universitari i Politècnic La Fe, Instituto de Salud Carlos III, Centro de Investigación Biomédica en Red de Cáncer, Novartis (Switzerland), The Ohio State University, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Moffitt Cancer Center, Tris Pharma (United States), University of Florence, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, University Hospital Leipzig, Hospital Clínic de Barcelona, Marien Hospital Düsseldorf, Centre Hospitalier Universitaire de Nice, Monash University, The Alfred Hospital, Sylvester Comprehensive Cancer Center, University of Miami, The US Oncology Network, Mayo Clinic, The University of Texas MD Anderson Cancer CenterSabatolimab (MBG453) Combination Treatment Regimens for Patients (Pts) with Higher-Risk Myelodysplastic Syndromes (HR-MDS): The MDS Studies in the Stimulus Immuno-Myeloid Clinical Trial Program
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
